Profiles of Switches in Patient with Ankylosing Spondylitis: Comparing Adalimumab, Etanercept, Infliximab, Golimumab and Certolizumab

Choquette Denis; Bessette Louis; Raynauld Jean-Pierre; Pelletier Jean-Pierre; Haraoui Boulos; Villeneuve Edith; Massicotte Frederic; Remillard Marie-Anais; Sauvageau Diane; Coupal Louis

首页> 外文期刊>The Journal of rheumatology >Profiles of Switches in Patient with Ankylosing Spondylitis: Comparing Adalimumab, Etanercept, Infliximab, Golimumab and Certolizumab

【24h】

Profiles of Switches in Patient with Ankylosing Spondylitis: Comparing Adalimumab, Etanercept, Infliximab, Golimumab and Certolizumab

机译：强直性脊柱炎患者开关的概况：比较阿达木单抗，依那西普，英夫利昔单抗，戈利木单抗和西妥珠单抗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of rheumatology》 |2015年第7期|共1页
作者
Choquette Denis; Bessette Louis; Raynauld Jean-Pierre; Pelletier Jean-Pierre; Haraoui Boulos; Villeneuve Edith; Massicotte Frederic; Remillard Marie-Anais; Sauvageau Diane; Coupal Louis;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Profiles of Switches in Patient with Ankylosing Spondylitis: Comparing Adalimumab, Etanercept, Infliximab, Golimumab and Certolizumab [J] . Choquette Denis, Bessette Louis, Raynauld Jean-Pierre, The Journal of rheumatology . 2015,第7期

机译：强直性脊柱炎患者开关的概况：比较阿达木单抗，依那西普，英夫利昔单抗，戈利木单抗和西妥珠单抗
2. Use of Monotherapy Anti-TNF Agents in Ankylosing Spondylitis Patients from the RHUMADATA (R) Registry: 8-year Comparative Effectiveness of Adalimumab, Etanercept and Infliximab [J] . Choquette Denis, Bessette Louis, Haraoui Boulos, The Journal of rheumatology . 2015,第7期

机译：从RHUMADATA（R）登记处对强直性脊柱炎患者使用单一疗法抗TNF药物：阿达木单抗，依那西普和英夫利昔单抗的8年比较疗效
3. Comparison of continuation rates with three TNF alpha antagonists (adalimumab, infliximab, etanercept) in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: Retrospective 10-year study [J] . Batteux Benjamin, Devauchelle Agathe, Boyard Pauline Lasselin, Joint, bone, spine : . 2016,第5期

机译：在类风湿性关节炎，强直性脊柱炎和银屑病关节炎中使用三种TNFα拮抗剂（阿达木单抗，英夫利昔单抗，依那西普）的持续率比较：回顾性10年研究
4. No adverse physiological responses to infrared whole body hyperthermia in patients with rheumatoid arthritis and ankylosing spondylitis compared to healthy subjects. [C] . F.G.J. OOSTERVELD, E. KOOPMAN, J. OLDE SCHOLTENHUIS, Advances in biomedical research . 2010

机译：与健康受试者相比，类风湿性关节炎和强直性脊柱炎患者对红外全身热疗没有不利的生理反应。
5. Altered CD8+ T Cell Function in Ankylosing Spondylitis: The Role of Perforin in Enhanced Inflammatory Profiles [D] . Yao, YuChen. 2018

机译：强直性脊柱炎中改变的CD8 + T细胞功能：穿孔素在增强炎症反应中的作用
6. Adalimumab etanercept infliximab certolizumab pegol golimumab tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation. [O] . Matt Stevenson, Rachel Archer, Jon Tosh, -1

机译：阿达木单抗依那西普英夫利昔单抗西妥珠单抗聚乙二醇戈利木单抗托珠单抗和阿巴西普用于治疗类风湿性关节炎该类风湿性关节炎以前未经疾病修饰抗风湿药治疗且仅在常规疾病修饰抗风湿药失败后进行：系统评价和经济评价。
7. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation. [O] . Stevenson M., Archer R., Tosh J., 2016

机译：阿达木单抗，依那西普，英夫利昔单抗，赛妥珠单抗，戈利木单抗，托西珠单抗和阿巴西普用于治疗以前未用改善疾病的抗风湿药物治疗的类风湿性关节炎，以及仅在传统的改善疾病的抗风湿药物失败后：系统评价和经济评价。

Profiles of Switches in Patient with Ankylosing Spondylitis: Comparing Adalimumab, Etanercept, Infliximab, Golimumab and Certolizumab

著录项

相似文献

相关主题

期刊订阅